Skip to Content


Audio: Conquest spring 2012

Conquest - Spring 2012


The audio version of the spring 2012 issue of Conquest is generously donated by Sight Into Sound (formerly Taping for the Blind). The narrator is Darrell K. Simmons.
Download audio from iTunes.

Complete issue

Spring 2012

This issue highlights anesthesiology's role in the OR, easing the cancer burden for underserved patients, development of cancer screening guidelines, a personalized approach to meeting cancer patients' nutritional needs and much more.


Anesthesia team focuses on the patient

MD Anderson's anesthesiology team evaluate, prepare and monitor every surgical patient, help with special procedures, conduct research and emphasize continued education.

Cultivating a new field

Anesthesiology technologists step up to enhance their contributions in MD Anderson's Operating Rooms.

The privilege is in the service

Since 1995, MD Anderson faculty and fellows have provided innovative and multidisciplinary cancer care for thousands of patients at Lyndon Baines Johnson General Hospital at no expense to Harris County.

Behind the scenes: A closer look at cancer screening guidelines

If the release of the U.S. Preventive Services Task Force recommendations on screening has taught us anything, it's that not all cancer screening guidelines are created equal.

Clinical nutrition: The personalized approach

Nutrition is an essential part of every cancer patient's care — from specialized dietitians to hotel-style room service for inpatients.

Picture This: Center for Targeted Therapy

As MD Anderson accelerates the delivery of new cancer drug therapies from concept to patients in the clinic, the Center for Targeted Therapy is playing a critical role.

Moving Forward: Connection becomes a circle of comfort

Three bladder cancer patients, matched by Anderson Network's Telephone Support Line, call on each other for support.

Signs of Hope: Voice Center

Doctors and staff in MD Anderson's Voice Center are working to restore voice to patients who have lost the ability to produce sound because of cancer or its treatments.


Institute gears up to develop better drugs faster

As leaders of MD Anderson's new Institute for Applied Cancer Science, Giulio Draetta, M.D., Ph.D., and Lynda Chin, M.D., have built a team of veteran scientists to swiftly and thoroughly evaluate cancer drug target candidates and ruthlessly select likely winners.

Drug that starves fat cells works for obese monkeys

Obese Rhesus monkeys treated with an experimental drug that starves fat cells by destroying their blood supply lost, on average, 11% of their body weight in four weeks.

New drug controls CLL in clinical trials

A promising oral drug for chronic lymphocytic leukemia has produced durable remissions for patients in clinical trials without triggering a debilitating side effect that's common with existing treatments.

Vorinostat enhances treatment for AML

Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85% remission rate after initial treatment.

Guidance for myelodysplastic syndromes

A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis.

Study questions popular radiation choice for breast cancer

An increasingly popular treatment choice for women with early-stage breast cancer may not be the answer for everyone.

New combination improves survival for metastatic breast cancer patients

In an international Phase III randomized study know as BOLERO-2, everolimus combined with the hormonal therapy exemestane has dramatically improved progression-free survival for women with metastatic breast cancer.

Cancer Briefings

Tribute to MD Anderson's third full-time president

A major building on MD Anderson's campus now bears the name of John Mendelsohn, M.D., to honor his 15-year leadership of the nation's largest cancer center.

A 15-minute investment in a longer life

Taiwanese who exercised for 15 minutes a day, or 92 minutes per week, extended their expected lifespan by three years compared to people who were inactive, according to a recent finding.

Care to Comment?

Email the editor to comment on a story or offer suggestions on topics you'd like to see covered in future issues of Conquest and Annual Report.

Make a difference

Your gift to MD Anderson makes a difference in the lives of cancer patients by supporting innovative patient care, research, education and prevention programs. You can Donate Now or learn more at myGiving to MD Anderson.

© 2015 The University of Texas MD Anderson Cancer Center